MAPT and Alzheimer disease: During the progression of AD, abnormal tau and Aβ proteins follow distinct sequences of deposition and have been used to define stages/phases (Braak staging for NFT and Thal phases for Aβ) of the disease, measured by postmortem examination of the brain [3].